Moderated by Erin McCreary, PharmD, Director of Infectious Diseases Improvement and Clinical Research Innovation at UPMC, Ghady Haidar, M.D., Director of Research, Bone Marrow Transplant and Hematological Malignancy Infectious Diseases at UPMC and Sam Aitken, PharmD, MPH, Clinical Pharmacist Specialist – Infectious Diseases, Michigan Medicine debated pros and cons during a live webinar on Jan. 25, 2023, at 1 p.m. EST.
Continuing Education credits (CE) for this event were only available to live learners and had to be completed by February 25, 2023. If you did not receive information about your live event CE, please email info@mad-id.org with any questions.
Enduring CE is not available for “A Pro/Con Debate on Treatments for Neutropenic Fever.”
You might also like…
ID Connect Named to Becker’s Health IT “Telehealth Companies to Know” List for the Third Year in a Row
Infectious Disease Connect Strengthens Clinical, Operational, and Growth Leadership Amid Continued Expansion
The Hidden Risks of Limited Infectious Diseases Coverage